SCTTF yields 4.02% · JNJ yields 2.13%● Live data
📍 SCTTF pulled ahead of the other in Year 1
Combined, SCTTF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of SCTTF + JNJ for your $10,000?
Scott Technology Limited, designs, manufactures, sells, and services automated and robotic production lines, and processes for various industries in New Zealand and internationally. The company operates through New Zealand manufacturing, Australia Manufacturing, Americas Manufacturing, Europe Manufacturing, and China Manufacturing segments. It offers rock crushers, pulverisers, ringmills, and reference materials for mining companies and laboratories under the Rocklabs brand name; bandsaw safety equipment for meat processing under the BladeStop brand name; and new and refurbished industrial robots under the RobotWorx brand name. Further, the company provides automated guided vehicles under the Transbotics brand name; palletising, conveying, and warehouse automation under the ALVEY brand name; and an industrial software under the MAESTRO+ brand name. It serves appliances, materials handling and logistics, meat processing, mining, and other industrial automation industries. Scott Technology Limited was founded in 1913 and is headquartered in Dunedin, New Zealand.
Full SCTTF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.